The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics

Table 8 Baseline-reported outcome scores for SF-36 domains in adult patients

SF-36 Domain	rhPTH(1-84) (n=63)		Conventional therapy (n=579)		Analysis population^a (N=642)
SF-36 Domain	n	Value	n	Value	n	Value
Physical functioning	62	43±11.6	525	47±10.1	587	47±10.3
Bodily pain	62	44±10.4	530	47±10.8	592	47±10.8
Role limitation – physical health	62	42±11.4	527	46±11.0	589	46±11.1
Role limitation – emotional problems	62	42±14.4	530	47±11.1	592	47±11.6
General health	61	41±10.4	528	46±11.5	589	45±11.5
Mental health	61	45±12.0	529	49±10.2	590	49±10.5
Social functioning	61	42±11.1	530	47±10.9	591	46±11.0
Vitality	61	42±11.5	529	47±11.1	590	47±11.2

All values are presented as mean ± SD
rhPTH(1-84) recombinant human parathyroid hormone (1-84), SF-36 36-Item Short Form Health Survey questionnaire for adults
^aBaseline is defined as the assessment at enrollment (visit 1); pediatric patients (n=27) and those who initiated rhPTH(1-84) before enrollment (n=68) were excluded from the analysis

ISSN: 1472-6823